After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Agios Pharmaceuticals Inc is $1.56B. A total of 0.55 million shares were traded on the day, compared to an average of 701.68K shares.
In the most recent transaction, FOUSE JACQUALYN A sold 7,497 shares of AGIO for 25.90 per share on Apr 10 ’25. After the transaction, the Director now owns 149,220 company shares. In a previous transaction on Apr 08 ’25, FOUSE JACQUALYN A bought 7,497 shares at 25.90 per share.
Among the insiders who sold shares, Burns James William disposed of 4,005 shares on Mar 03 ’25 at a per-share price of $35.54. This resulted in the Chief Legal Officer holding 18,650 shares of AGIO after the transaction. In another insider transaction, Jones Cecilia sold 2,275 shares at $35.54 per share on Mar 03 ’25. Company shares held by the Chief Financial Officer now total 21,843.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, AGIO has a high of $62.58 and a low of $23.42.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. AGIO’s latest balance sheet shows that the firm has $1.02B in Cash & Short Term Investments as of fiscal 2021. There were $97.09M in debt and $59.83M in liabilities at the time. Its Book Value Per Share was $26.96, while its Total Shareholder’s Equity was $1.29B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AGIO is Buy with a score of 4.22.
